Intel Corp. (NASDAQ:INTC): Closing price $22.99
Intel is developing a new line of ultra-small and ultra-low-power microchips created for wearable devices such as smart watches and bracelets, representing a venture by the firm to ensure its place at the center of the next big tech wave after coming in late to the smartphone and tablet upheaval. The new series of chips, named Intel Quark, will ship in 2014, and include an ingestible version aimed at biomedical uses, according to Intel President Renee James, who spoke to reporters late Monday.
Cree Inc. (NASDAQ:CREE): Closing price $60.04
The most recent Cree innovation, the Cree TW Series LED Bulb, is making waves. The revolutionary bulb emits natural LED light, establishing a new standard with a Color Rendering Index of 93. Cree is the first firm to satisfy the California Energy Commission LED bulb specification. The new TW Series bulb appears to be a lightbulb, lights up as a lightbulb, and provides consumers another reason to switch to LED. The new bulb is available at $19.97 for the 60-watt replacement.
ManTech International Corp. (NASDAQ:MANT): Closing price $28.50
ManTech was awarded a contract by the U.S. Navy to support war fighting, manpower, and business transformation initiatives for the Deputy Chief of Naval Operations, Information Dominance (DCNO N2/N6). The indefinite delivery, indefinite quantity contract tops out at $49.2 million, with a period of performance of one base year and two option years. ManTech will supply strategic and operational level support for the review of DCNO N2/N6 processes, organizational structures, and continuing efficiency efforts. Included in this support is data collection, programmatic analysis, process research, intelligence analysis, and strategic planning and analyses, along with others.
UnitedHealth Group Inc. (NYSE:UNH): Closing price $74.63
UnitedHealth has recalled software employed in hospital emergency departments in more than 20 states due to an error that caused doctors’ notes about patient prescriptions to disappear from their files. Certain versions of the software made by the health insurer had a glitch that failed to print information connected with the medication and failed to add data to patients’ charts, according to a document filed with the Food and Drug Administration and posted July 29. The tech in question is used in 35 facilities across the 20 states.